lactic acid has been researched along with oxazolidin-2-one in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mensa, J; MirĂ³, O; Soriano, A | 1 |
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Carcillo, JA; Crowley, K; Michaels, MG; Su, E | 1 |
Boret, H; Cotte, J; Cungi, PJ; Esnault, P; Romanat, PE | 1 |
Girotra, P; Kumar, G; Singh, SK | 1 |
5 other study(ies) available for lactic acid and oxazolidin-2-one
Article | Year |
---|---|
Mitochondrial toxicity associated with linezolid.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Asthenia; Brain Abscess; Electron Transport Complex II; Electron Transport Complex IV; Gram-Positive Bacterial Infections; Humans; Lactic Acid; Linezolid; Male; Mitochondria; Mitochondrial Diseases; Oxazolidinones; Prosthesis-Related Infections | 2005 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children.
Topics: Acetamides; Acidosis, Lactic; Adolescent; Anti-Bacterial Agents; Fatal Outcome; Female; Humans; Infant; Lactic Acid; Linezolid; Male; Mitochondria; Oxazolidinones | 2011 |
Linezolid-induced hyperlactatemia in a burn patient.
Topics: Acetamides; Aged, 80 and over; Anti-Infective Agents; Burns; Female; Humans; Lactic Acid; Linezolid; Oxazolidinones; Skin Transplantation; Staphylococcal Infections | 2013 |
Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
Topics: Animals; Brain; Calorimetry, Differential Scanning; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Design; Drug Liberation; Lactic Acid; Male; Mice; Migraine Disorders; Nanoparticles; Oxazolidinones; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Serotonin 5-HT1 Receptor Agonists; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Tryptamines; X-Ray Diffraction | 2016 |